Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease (Q40084730)

17 September 2017

Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease (English)

1 reference

17 September 2017

1 reference

Rohita Sharma

1

1 reference

17 September 2017

Catherine R McMillan

series ordinal

2

1 reference

17 September 2017

Lennard P Niles

series ordinal

3

1 reference

17 September 2017

language of work or name

1 reference

1 October 2007

1 reference

Journal of Pineal Research

17 September 2017

1 reference

17 September 2017

43

1 reference

17 September 2017

3

1 reference

17 September 2017

245-254

1 reference

Adult neurogenesis and neural stem cells of the central nervous system in mammals

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Concise review: therapeutic strategies for Parkinson disease based on the modulation of adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Multipotent neural cell lines can engraft and participate in development of mouse cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Cholinergic expression by a neural stem cell line grafted to the adult medial septum/diagonal band complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Factors promoting survival of mesencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Simplified mammalian DNA isolation procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin mitigates mitochondrial malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin regulation of antioxidant enzyme gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Protective effect of melatonin in a chronic experimental model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Role of extracellular signal regulated kinases 1 and 2 in neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Stem cells in the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00469.X

10.1111/J.1600-079X.2007.00469.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference